Clinical trial
Phase I Vaginal Microbicide Study of BufferGel
NCT00000927 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Vaginal Microbicide Study of BufferGel
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- 40
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.